Thromboembolic NSTEMI from a 9.4 × 7.3 mm mid-left circumflex artery aneurysm with a zero calcium score and non-obstructive coronary arteries

Abdelrahman Shehata1, Gargi Sharma1, Md Abdus Sakur1, Alina Hakim1, Dristi Naraindas Varandani2, Mohamed Hussien Abbas3

1 College of Medicine, Gulf Medical University, Ajman, UAE

2 Thumbay University Hospital, Ajman, UAE

3 Cardiology Department, Rashid Hospital, Dubai, UAE

Corresponding author’s e-mail: abdoseif990000@gmail.com

Received: 10/04/2026
Accepted: 18/04/2026
Published: 14/05/2026

Conflicts of Interests: The Authors declare that there are no competing interests.
Patient Consent: Written informed consent was obtained from the patient for publication of this case report and accompanying images.
Acknowledgments: It is with great pleasure that we extend our heartfelt thanks to the entire medical staff at Rashid Hospital, Dubai Health Authority, who have helped immensely in this diagnosis and its management. Our deepest appreciation goes out to the physician involved in our supervision during the treatment process and the compilation of this article. Finally, we are grateful to the patient involved in this case presentation for allowing us to use it for academic reasons.
This article is licensed under a CC Attribution-NonCommercial-NoDerivatives 4.0 License

How to cite this article: Shehata A, Sharma G, Sakur A, Hakim A, Naraindas Varandani D, Abbas MH. Thromboembolic NSTEMI from a 9.4 × 7.3 mm mid-left circumflex artery aneurysm with a zero calcium score and non-obstructive coronary arteries. EJCRIM 2026;13:doi:10.12890/2026_006148

ABSTRACT

Introduction: Coronary artery aneurysms (CAAs) are uncommon and can cause acute coronary syndromes due to thromboembolism despite the absence of obstructive coronary disease.
Case description: We report the case of a 51-year-old patient with hypertension and hypercholesterolemia with the chief complaint of chest pain and elevated troponin, which is typical of non-ST-segment elevation myocardial infarction (NSTEMI). Coronary angiography showed non-obstructive coronary arteries and a calcium score of 0 with 9.4 x 7.3 mm middle-left circumflex artery aneurysm with thrombosis. Thrombus aspiration was effectively done without stenting. The patient was treated using dual antiplatelet therapy and statin therapy, and clinical improvement was achieved. The case in point demonstrates an infrequent pathophysiology of NSTEMI due to thromboembolism in a tiny aneurysm without severe atherosclerosis. Multimodality imaging was essential for diagnosis. Management was conservative. Transthoracic echocardiography revealed mild left ventricular hypertrophy with inferior hyperkinesia along with preserved ejection fraction. The patient was hemodynamically stable throughout hospitalization and was discharged on optimal medical therapy having no recurrent symptoms.
Conclusion: NSTEMI may be caused by small CAAs through thromboembolism even though the coronary artery calcium score is zero. Personalized care (thrombus aspiration and optimal medical therapy) can yield excellent outcomes.

KEYWORDS

Coronary artery aneurysm, NSTEMI, thromboembolism, zero calcium score, non-obstructive coronary artery disease

LEARNING POINTS

INTRODUCTION

Coronary artery aneurysm (CAA), which is defined as localized dilatation of a coronary artery that is more than 1.5× the surrounding vessel diameter, is rare, with a reported prevalence of 0.3-5% in angiographic studies[1]. Even though CAAs are often incidental findings they can cause complications such as thrombosis and distal embolization.

In adults, CAAs are usually linked to atherosclerosis, and other causes include inflammatory diseases, congenital defects, and iatrogenic factors[2]. CAAs cause acute coronary syndrome (ACS) that are uncommon and generally associated with the formation of thrombus as opposed to the rupture of the plaque.

CASE DESCRIPTION

The patient was a 51-year-old Emirati male patient diagnosed with hypertension and hypercholesterolemia who presented with acute chest pain. He had a history of inferior ST-segment elevation myocardial infarction, with no diabetes, smoking or family history of premature coronary disease.

At admission, he was hemodynamically stable. In addition, ischemic symptoms and the absence of ST elevation on the electrocardiogram (ECG), the troponin level was high and therefore a diagnosis of NSTEMI was made. Dilated inferior Q waves without fresh ischemic alterations were observed on ECG (Fig. 1).

(click to enlarge)

Figure 1. Admission 12-lead electrocardiogram showcasing normal sinus rhythm with old inferior Q waves and no acute ischemic changes.

The laboratory results showed high total cholesterol (6.8 mmol/l) and low-density lipoprotein cholesterol (2.9 mmol/l), normal haemoglobin A1C and C-reactive protein (Table 1).

(click to enlarge)

Table 1. Laboratory investigations performed on admission (November 6-7, 2025). No serial measurements of troponin or lipids were reported in this admission.
Abbreviations: HbA1c, haemoglobin A1c; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

Transthoracic echocardiography revealed mild left ventricular hypertrophy, inferior hypokinesia and maintained ejection fraction (50-55%).

Coronary angiography showed that the coronary arteries were non-obstructed and right dominance. Computed tomography coronary angiography (CTCA) was performed and showed a coronary artery calcium score of zero, a 9.4 × 7.3 mm aneurysm in the mid left circumflex artery and a thrombus (Fig. 2).

(click to enlarge)

Figure 2. Coronary angiography (left anterior oblique caudal view) showing a small mid-left circumflex artery aneurysm (9.4 × 7.3 mm) with surrounding thrombus (arrow) in a patient with non-obstructive coronary arteries along with a calcium score of zero.

Thrombus aspiration was successfully done without placing stents because there was no major stenosis. The patient received dual antiplatelet therapy (aspirin and ticagrelor), high-intensity statin therapy and antihypertensive medications. At discharge, on day 5 he had no symptoms in stable condition.

DISCUSSION

This case indicates that thromboembolism caused by a small CAA is a rare cause of NSTEMI even in the absence of obstructive coronary artery disease.

Though CAAs are rare, they may cause thrombosis and embolization[3]. NSTEMI in a patient with a zero coronary artery calcium score and no obstruction of the coronary arteries is uncommon and indicates a non-atherosclerotic process[4].

The size of the aneurysm (9.4 mm) was in the small-to-moderate size range and yet represented a considerable thromboembolic risk. Smaller aneurysms are less well defined than giant aneurysms but may still lead to acute events unlike giant aneurysms which are usually associated with Kawasaki disease.

The imaging of multimodality was essential in this case. The coronary angiography made it possible to detect and treat thrombus, whereas CTCA made it possible to measure the aneurysm correctly and guarantee the lack of calcification[5,6].

Management strategies for CAAs are not standardized because of a scarcity of evidence. CAAs can be treated by medical therapy, percutaneous intervention, or surgery depending on aneurysm size, signs, and complications[5,6]. Conservative management in this instance, which included thrombus aspiration and dual antiplatelet therapy, was effective, and prevented the use of stents which were not necessary[7,8].

The case demonstrates that mechanisms other than plaque rupture can cause ACS. Further, it is important to take into account CAAs with atypical presentations.

There is an absence of obstructive coronary disease along with a zero coronary artery calcium score of zero. Hence, this case shows the significance of considering alternative mechanisms of myocardial infarction beyond conventional atherosclerotic plaque rupture[9].

CAA must be included in the differential diagnosis of ACS specifically when imaging and clinical findings are discordant. Moreover, tailored treatment strategies based on clinical along with anatomical factors are critical to optimize outcomes and avoid unnecessary invasive interventions[10].

References

  1. Sannino M, Nicolai M, Infusino F, Giulio L, Usai TL, Biscotti G, et al. Coronary Artery Aneurysms: A Clinical Case Report and Literature Review Supporting Therapeutic Choices. J Clin Med 2024;13:5348. doi: 10.3390/jcm13185348
  2. Gong X, Zhang H, Peng W, Yang G, Xiao Z. Case report: Multimodality imaging revealing ruptured giant coronary artery aneurysm presenting with hemoptysis. Front Cardiovasc Med 2023;10:1185089. doi: 10.3389/fcvm.2023.1185089
  3. Matta AG, Yaacoub N, Nader V, Moussallem N, Carrie D, Roncalli J. Coronary artery aneurysm: A review. World J Cardiol 2021;13:446-455. doi: 10.4330/wjc.v13.i9.446
  4. Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv 2018;11:1211-1223. doi: 10.1016/j.jcin.2018.02.041
  5. Abou Sherif S, Ozden Tok O, Taşköylü Ö, Goktekin O, Kilic ID. Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Front Cardiovasc Med 2017;4:24. doi: 10.3389/fcvm.2017.00024
  6. Núñez-Gil IJ, Cerrato E, Bollati M, Nombela-Franco L, Terol B, Alfonso-Rodríguez E, et al. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR). Int J Cardiol 2020;299:49-55. doi: 10.1016/j.ijcard.2019.05.067
  7. Thangathurai J, Kalashnikova M, Takahashi M, Shinbane JS. Coronary Artery Aneurysm in Kawasaki Disease: Coronary CT Angiography through the Lens of Pathophysiology and Differential Diagnosis. Radiol Cardiothorac Imaging 2021;3:e200550. doi: 10.1148/ryct.2021200550
  8. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017;135:e927-e999. doi: 10.1161/CIR.0000000000000484. Erratum in: Circulation 2019;140:e181-e184. doi: 10.1161/CIR.0000000000000703
  9. van Stijn D, Korbee JM, Netea SA, de Winter VC, Zwinderman KAH, Kuipers IM, et al. Treatment and Coronary Artery Aneurysm Formation in Kawasaki Disease: A Per-Day Risk Analysis. J Pediatr 2022;243:167-172.e1. doi: 10.1016/j.jpeds.2021.12.054
  10. Liu J, Yue Q, Qin S, Su D, Ye B, Pang Y. Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease. Front Cardiovasc Med 2022;9:969495. doi: 10.3389/fcvm.2022.969495